Novartis AG ADR (NYSE:NVS) - Share price - Overview

Stock Report

Novartis AG NVS

Last Price
$76.79

Day Change
-0.27|-0.35%

As of 21/05/2018
16:11:03 EDT | USD
Minimum 15 Minutes Delay.

Last Close77.06
Day Range76.75 - 77.47
Mkt Cap179.10Bil
52-Wk Range75.73 - 94.19
Yield %3.86
ISINUS66987V1098
Volume986,950
P/E22.52
P/S3.55
P/CF13.85

Share Price

Financials
201520162017
More ...
Income Statement
Revenue50,387.0049,436.0050,135.00
Operating Income6,928.006,341.006,660.00
Net Income17,783.006,712.007,703.00
Basic EPS7.402.823.28
Avg. Diluted Shares Outstanding2,4032,4002,371
Balance Sheet
Current Assets22,845.0024,931.0028,208.00
Non Current Assets108,711.00105,193.00104,871.00
Total Assets131,556.00130,124.00133,079.00
Current Liabilities23,708.0022,209.0023,403.00
Total Liabilities---
Total Equity77,046.0074,832.0074,168.00
Cash Flow
Operating Cash Flow11,897.0011,475.0012,621.00
Capital Expenditure-3,505.00-2,879.00-2,746.00
Free Cash Flow8,392.008,596.009,875.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

124,000
Key Stats
More ...
Price/Earning TTM22.34
Price/Book2.53
Price/Sales TTM3.55
Rev Growth (3 year avg)-2.22
EPS Growth (3 year avg)-
Operating Margin % TTM13.28
Net Margin % TTM15.36
ROE TTM10.34
Debt/Equity0.31
Dividends
PreviousLatest
More ...
Declared Date06/02/1724/02/18
Ex-Div01/03/1706/03/18
Paid20/04/17t.b.c.
Amnt2.722.98
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.